Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

FIBRINOGEN - ANVISA Registration 10159820262

Access comprehensive regulatory information for FIBRINOGEN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10159820262 and manufactured by EBRAM PRODUTOS LABORATORIAIS LTDA. The registration is held by EBRAM PRODUTOS LABORATORIAIS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including BIOSYSTEMS S.A., ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
10159820262
Registration Details
ANVISA Registration Number: 10159820262
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

EBCOAG FIB - Fibrinogênio
Risk Class II

Registration Details

10159820262

25351386610202416

50657402000131

Company Information

Brazil
PT: BRASIL

Dates and Status

Sep 09, 2024

VIGENTE

09/18/2025 19:00:01